Skip to main content
Alzheimer's Research & Therapy logoLink to Alzheimer's Research & Therapy
. 2023 Aug 21;15:139. doi: 10.1186/s13195-023-01284-9

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline

Justin Bauzon 1, Garam Lee 2, Jeffrey Cummings 2,3,
PMCID: PMC10440904  PMID: 37605263

Correction : Alzheimers Res Ther 12, 98 (2020)

https://doi.org/10.1186/s13195-020-00662-x

Following the publication of the original article [1], the authors would like to correct the three occurrences of Dr. Jeffrey Cummings’s initial in Competing interests section from "JL" to "JC”.

The original article [1] has been updated.

Reference

  • 1.Bauzon J, Lee G, Cummings J. Repurposed agents in the Alzheimer’s disease drug development pipeline. Alzheimers Res Ther. 2020;12:98. doi: 10.1186/s13195-020-00662-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Alzheimer's Research & Therapy are provided here courtesy of BMC

RESOURCES